Related Experiment Video
Updated: Feb 11, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosis
Alireza Abdolrasouli1, Amelia C Bercusson1, Johanna L Rhodes2
1Fungal Pathogens Laboratory, National Heart and Lung Institute, Imperial College London, London, UK.
Abstract:
Infections caused by Rasamsonia argillacea complex have been reported in various clinical settings. Cystic fibrosis (CF) is one of the main underlying conditions. An observational cohort study of CF patients with Rasamsonia in respiratory samples was conducted. Eight isolates from 6 patients were identified as R. argillacea complex and tested for antifungal susceptibility. All isolates had high MICs to voriconazole and posaconazole and low MECs to echinocandins. Four patients experienced lung function decline in the year preceding first Rasamsonia isolation. This continued in the year following first isolation in 3 out of 4 cases. Antifungal therapy was initiated in 2 patients, to which only one exhibited a clinical response. Three out of 6 patients died within 3 years of isolating Rasamsonia. Genotyping suggests that similar genotypes of Rasamsonia can persist in CF airways. Consistent with other fungi in CF, the clinical impact of airway colonisation by Rasamsonia is variable. In certain patients, Rasamsonia may be able to drive clinical decline. In others, though a clear impact on lung function may be difficult to determine, the appearance of Rasamsonia acts as a marker of disease severity. In others it does not appear to have an obvious clinical impact on disease progression.
Insights
Rasamsonia argillacea complex infections in cystic fibrosis (CF) patients show variable clinical impact. Antifungal susceptibility testing revealed resistance to azoles but susceptibility to echinocandins, with some patients experiencing lung function decline.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Rasamsonia argillacea complex (RAC) infections are increasingly reported in clinical settings.
- Cystic fibrosis (CF) is a significant underlying condition associated with RAC colonization.
- The clinical significance and antifungal susceptibility of RAC in CF patients require further investigation.
Purpose of the Study:
- To investigate the clinical impact of RAC colonization in CF patients.
- To determine the antifungal susceptibility profile of RAC isolates from CF patients.
- To explore the persistence and genotypic characteristics of RAC in CF airways.
Main Methods:
- Observational cohort study of CF patients with RAC in respiratory samples.
- Identification and antifungal susceptibility testing (MICs for azoles, MECs for echinocandins) of 8 RAC isolates from 6 patients.
- Genotyping of RAC isolates to assess persistence.
Main Results:
- All 8 RAC isolates exhibited high Minimum Inhibitory Concentrations (MICs) to voriconazole and posaconazole, and low Minimum Effective Concentrations (MECs) to echinocandins.
- Four out of six patients experienced lung function decline around the time of RAC isolation.
- Three patients died within 3 years of RAC isolation; only one of two treated patients responded to antifungal therapy.
Conclusions:
- RAC colonization in CF airways can be persistent, with similar genotypes observed.
- The clinical impact of RAC in CF is variable, ranging from driving clinical decline to acting as a marker of disease severity or having no obvious impact.
- RAC isolates demonstrate intrinsic resistance to azoles and susceptibility to echinocandins, guiding potential therapeutic strategies.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Emerging Adulthood
Introduction Cardiac Emergencies
Suctioning the Nasopharyngeal Airway
Equipment Required
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...

